Birdwatch Note
2023-12-16 18:52:11 UTC - NOT_MISLEADING
I reported IVM use to pro med groups of doctors,nurses, etc. But IVM was often misused (doses too high/late/just one dose,etc.)BUT VIZ: "Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner …" https://www.proquest.com/openview/202aa9f013b8a529e202c0a1da13d0a5/1?pq-origsite=gscholar&cbl=2045583 and https://www.medrxiv.org/content/10.1101/2020.10.29.20222661v1
Written by FF614092EC4515405AEAB3A01A50673CFBC895CFBB1651631E7DA7A69F2D406B
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1735901914662080762
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1736096902674841825
- noteId - 1736096902674841825
- participantId -
- noteAuthorParticipantId - FF614092EC4515405AEAB3A01A50673CFBC895CFBB1651631E7DA7A69F2D406B Participant Details
- createdAtMillis - 1702752731365
- tweetId - 1735901914662080762
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 1
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- I reported IVM use to pro med groups of doctors,nurses, etc. But IVM was often misused (doses too high/late/just one dose,etc.)BUT VIZ: "Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner …" https://www.proquest.com/openview/202aa9f013b8a529e202c0a1da13d0a5/1?pq-origsite=gscholar&cbl=2045583 and https://www.medrxiv.org/content/10.1101/2020.10.29.20222661v1
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-12-16 18:52:11 UTC (1702752731365) |
1969-12-31 23:59:59 UTC (-1) |
2023-12-17 02:05:57 UTC (1702778757358) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-12-16 16:33:48 -0600 | Rating Details | |
2023-12-16 14:30:27 -0600 | Rating Details | |
2023-12-16 13:25:51 -0600 | Rating Details | |
2023-12-16 20:36:03 -0600 | Rating Details | |
2023-12-18 04:10:42 -0600 | Rating Details | |
2024-01-09 16:34:56 -0600 | Rating Details | |
2024-01-29 05:54:04 -0600 | Rating Details |